The Latest Breaking News from diabetes

Plantwatch: how goat’s rue inspired super drug for everything from diabetes to obesity

Galegine compound in plant formed blueprint for metformin drug, but without the toxic side-effects

The Guardian - UK · May 20

Stem cells have potent potential for diabetes treatment

Humans have around 30 trillion cells in our adult bodies. Amazingly, each of these cells came from a handful of about 100 stem cells in the earliest days of development. The ability of these embryonic stem cells to turn into any cell type makes them pluripotent — something that researchers…

The Conversation · May 19

NHS rollout of artificial pancreas narrows inequality in diabetes care

People from deprived and minority ethnic backgrounds have better access to device than for previous technologies

The Guardian - UK · May 19

No Candy, No Soda: 4 States Are Banning Sugary Treats for SNAP Users – How This Could Spread Nationwide

Families using SNAP benefits could soon notice major changes at grocery store checkout lines. Several states are now moving to block purchases of soda, candy, and other sugary snacks with Supplemental Nutrition Assistance Program benefits, arguing that taxpayer-funded food assistance should promote healthier eating habits. Indiana, Nebraska, Utah, and West…

Budget and the Bees · May 18

From PCOS to PMOS: What the name change to polyendocrine metabolic ovarian syndrome means for women’s health

“Hopeful,” “excited” and “helpful” for the future of women’s health — these are just some of the words expressed by the team that worked together for more than a decade to change the name polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS).

The Conversation · May 18

Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification

Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and inventory-related factors, while emphasizing that the diabetes device maker is continuing a broader diversification

MarketBeat · May 16

Managing Gestational Diabetes Glucose With Friendly Eating Insulin Support and a Practical Gestational Diabetes Diet

Learn how gestational diabetes affects glucose and insulin, why gestational diabetes screening matters, and how a balanced gestational diabetes diet supports a healthy pregnancy.

Medical Daily · May 16

4 High-Use Drugs That Will Have Lower Medicare Prices — And 3 Others Facing Negotiations

Millions of seniors are finally seeing relief from some of the highest prescription drug costs in America as Medicare’s new drug price negotiation program begins...

Saving Advice · May 16

DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day

DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for continuous glucose monitoring, international expansion and margin improvement. President and Chief Executive Officer Jake Leach said the company’s next phase

MarketBeat · May 16

Dr Reddy’s launches generic Semaglutide injection, popular weight-loss drug, in Canada

Dr Reddy's Laboratories has launched its generic Semaglutide injection in Canada. This marks a significant step for the company in providing treatment for type 2 diabetes. Canada is the first G7 nation to approve this medication. The launch follows a recent introduction in India. Dr Reddy's aims to expand access…

The Economic Times · May 16